#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12196	16S	1529	1529	100.0	16S.l15.c4.ctg.2	2230	537.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1430	1430	C	644	C	631	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12196	16S	1529	1529	100.0	16S.l15.c4.ctg.2	2230	537.2	0	HET	.	.	.	C451T,A	.	451	451	C	697	697	C	720	C,T,A	554,144,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12196	16S	1529	1529	100.0	16S.l15.c4.ctg.2	2230	537.2	0	HET	.	.	.	C207T,G	.	207	207	C	453	453	C	691	C,T,G	523,144,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22290	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3612	609.9	0	.	n	.	0	T695C	SNP	695	695	T	1057	1057	C	653	C	641	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22290	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3612	609.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2333	2333	C	641	C,G	625,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22290	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3612	609.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2407	2407	A	671	A	656	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22290	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3612	609.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2959	2959	C	633	C	616	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1554	folP	855	855	100.0	folP.l15.c4.ctg.1	1762	87.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1079	1081	AGC	141;143;144	A;G;C	137;137;138	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4490	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3554	125.0	1	SNP	p	S91F	1	.	.	271	273	TTC	641	643	TTC	143;142;145	T;T;C	141;139;143	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4490	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3554	125.0	1	SNP	p	G95N	0	.	.	283	285	GGC	653	655	GGC	149;148;152	G;G;C	146;146;150	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4490	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3554	125.0	1	SNP	p	D95G	1	.	.	283	285	GGC	653	655	GGC	149;148;152	G;G;C	146;146;150	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1330	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1459	89.6	1	SNP	p	G45D	0	.	.	133	135	GGC	595	597	GGC	157;150;150	G;G;C,T	154;147;145,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	720	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	913	78.0	0	.	n	.	0	A197.	DEL	197	197	A	527	527	A	147	A	146	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3968	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3026	129.4	0	.	p	.	0	P269S	NONSYN	805	807	CCG	1100	1102	TCG	132;132;128	T,C;C;G	121,1;128;121	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3968	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3026	129.4	1	SNP	p	D86N	0	.	.	256	258	GAC	551	553	GAC	175;176;176	G;A,C;C	172;162,1;175	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3968	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3026	129.4	1	SNP	p	R87I	0	.	.	259	261	CGT	554	556	CGT	176;176;174	C;G;T,C	174;172;166,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3968	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3026	129.4	1	SNP	p	R87W	0	.	.	259	261	CGT	554	556	CGT	176;176;174	C;G;T,C	174;172;166,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3968	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3026	129.4	1	SNP	p	S87R	1	.	.	259	261	CGT	554	556	CGT	176;176;174	C;G;T,C	174;172;166,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	3968	parC	2304	2304	99.96	parC.l15.c4.ctg.1	3026	129.4	1	SNP	p	S88P	0	.	.	262	264	TCC	557	559	TCC	174;175;177	T;C;C	170;173;176	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3300	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2619	124.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1490	1492	GGC	161;158;155	G,A;G;C	157,1;152;145	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1341	1343	GCC	175;179;178	G;C;C	171;177;175	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1344	1346	ATG	181;183;185	A;T;G	177;179;182	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1356	1358	ACC	182;186;187	A;C;C	178;184;181	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1356	1358	ACC	182;186;187	A;C;C	178;184;181	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1857	1859	ACC	158;157;159	A;C;C	149;152;155	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1911	1913	GCG	158;156;157	G;C,T;G	154;150,1;153	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1911	1913	GCG	158;156;157	G;C,T;G	154;150,1;153	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2034	2036	GGT	116;114;111	G;G;T	114;112;109	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2043	2045	AGC	111;110;110	A,G;G;C	106,1;106;103	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3334	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2565	128.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2061	2063	CCG	83;84;85	C,G;C;G	77,1;73;67	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4514	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2974	149.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1608	1610	CCG	161;160;158	C;C,T;G	155;155,1;150	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2016	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2065	96.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	690	690	C	126	C	119	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2104	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1561	131.4	0	.	p	.	0	E209K	NONSYN	625	627	GAA	1030	1032	AAA	180;181;183	A,G;A;A	174,1;180;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2104	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1561	131.4	0	.	p	.	0	A212E	NONSYN	634	636	GCA	1039	1041	GAA	184;187;186	G;A,C;A	180;181,2;184	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2104	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1561	131.4	1	SNP	p	G120K	1	.	.	358	360	AAG	763	765	AAG	169;170;166	A,G;A,G;G,C	162,1;163,1;153,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2104	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1561	131.4	1	SNP	p	A121N	1	.	.	361	363	AAC	766	768	AAC	165;166;166	A,G;A,C;C	159,1;156,1;160	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2104	porB1b	1038	1038	99.81	porB1b.l15.c30.ctg.1	1561	131.4	1	SNP	p	N121D	0	.	.	361	363	AAC	766	768	AAC	165;166;166	A,G;A,C;C	159,1;156,1;160	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7998	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4838	163.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	896	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1061	82.7	1	SNP	p	V57M	1	.	.	169	171	ATG	530	532	ATG	158;159;158	A;T;G	156;158;154	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
